ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
UCB NPV (PK)

UCB NPV (PK) (UCBJF)

199.9191
1.64
(0.83%)
Closed December 29 3:00PM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
199.9191
Bid
191.48
Ask
206.05
Volume
24
199.9191 Day's Range 199.9191
87.10 52 Week Range 199.9191
Market Cap
Previous Close
198.275
Open
199.9191
Last Trade
24
@
199.9191
Last Trade Time
Financial Volume
US$ 4,798
VWAP
199.9191
Average Volume (3m)
309
Shares Outstanding
189,594,898
Dividend Yield
-
PE Ratio
106.49
Earnings Per Share (EPS)
1.81
Revenue
4.87B
Net Profit
343M

About UCB NPV (PK)

UCB, Brussels, Belgium is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. UCB, Brussels, Belgium is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.

Sector
Pharmaceutical Preparations
Industry
Chemicals & Allied Products
Website
Headquarters
Brussels, Brussels-capital Region, Bel
Founded
1928
UCB NPV (PK) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker UCBJF. The last closing price for UCB NPV (PK) was US$198.28. Over the last year, UCB NPV (PK) shares have traded in a share price range of US$ 87.10 to US$ 199.9191.

UCB NPV (PK) currently has 189,594,898 shares outstanding. The market capitalization of UCB NPV (PK) is US$37.59 billion. UCB NPV (PK) has a price to earnings ratio (PE ratio) of 106.49.

UCBJF Latest News

Bristol Myers Deal Overshadows Q4 loss at Five Prime - Analyst Blog

Five Prime Therapeutics, Inc. (FPRX) has been in the news over the past few days. Investors at Five Prime, which went public in September last year, had plenty to cheer when the company inked a...

Data on UCB's Neupro - Analyst Blog

UCB (UCBJF) recently presented data from a study showing the effect of Neupro on cardiovascular measures in patients with restless legs syndrome (RLS). The double-blind, placebo-controlled...

Nektar Posts Wider Loss, Maintains View - Analyst Blog

Nektar Therapeutics (NKTR) reported a loss of 48 cents per share in the first quarter of 2013, wider than the year-ago loss of 34 cents and the Zacks Consensus Estimate of a loss of 41 cents...

Questcor Misses on Earnings, Revs - Analyst Blog

Questcor Pharmaceuticals Inc. (QCOR) reported first quarter 2013 adjusted earnings per share of 67 cents, up 15.5% from the year-ago period. Earnings were, however, well below the Zacks...

Valeant Beats Earnings, Misses Revs - Analyst Blog

Valeant Pharmaceuticals’ (VRX) first quarter 2013 earnings of $1.27 (excluding special items but including stock-based compensation expense) were short of the Zacks Consensus Estimate by a...

Shire Beats Earnings in 1Q - Analyst Blog

Shire’s (SHPG) first quarter 2013 earnings (excluding special items) of 1.63 as per American Depositary Share (ADS) beats the Zacks Consensus Estimate of $1.61. The reported...

Glaxo's Trametinib Delayed - Analyst Blog

Recently, GlaxoSmithKline (GSK) announced that the US Food and Drug Administration (FDA) has extended the review period for Glaxo’s oncology candidate, trametinib, by three months. A final...

ViroPharma Reports Loss in 1Q - Analyst Blog

ViroPharma Inc.’s ( VPHM ) first quarter 2013 adjusted loss (excluding special items but including stock-based compensation) came in at 7 cents per share compared to year-ago earnings...

Actavis Beats on Earnings, Raises View - Analyst Blog

Actavis, Inc.’s (ACT) first quarter 2013 earnings of $1.99 per share beat the Zacks Consensus Estimate of $1.87 and increased 21% from the year-ago earnings. Revenues for the reported...

Loss Widens at Momenta - Analyst Blog

Momenta Pharmaceuticals Inc. (MNTA) reported first quarter 2013 net loss per share of 48 cents, wider than the Zacks Consensus Estimate of a loss of 43 cents and the year-ago loss of 10...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
11.64410.829201866095198.275199.9191198.27580198.275CS
44.04412.0646330568195.875199.9191195.87556197.01139053CS
1215.91918.65168478261184199.9191174309187.28624306CS
2650.039133.3861088871149.88199.9191149.85231178.70034495CS
52112.8191129.52824339887.1199.919187.1290142.70207939CS
15687.369177.6269213683112.55199.919168.30106267593.63875022CS
260118.5191145.60085995181.4199.919167.39107892.37454781CS

UCBJF - Frequently Asked Questions (FAQ)

What is the current UCB NPV (PK) share price?
The current share price of UCB NPV (PK) is US$ 199.9191
How many UCB NPV (PK) shares are in issue?
UCB NPV (PK) has 189,594,898 shares in issue
What is the market cap of UCB NPV (PK)?
The market capitalisation of UCB NPV (PK) is USD 37.59B
What is the 1 year trading range for UCB NPV (PK) share price?
UCB NPV (PK) has traded in the range of US$ 87.10 to US$ 199.9191 during the past year
What is the PE ratio of UCB NPV (PK)?
The price to earnings ratio of UCB NPV (PK) is 106.49
What is the cash to sales ratio of UCB NPV (PK)?
The cash to sales ratio of UCB NPV (PK) is 7.5
What is the reporting currency for UCB NPV (PK)?
UCB NPV (PK) reports financial results in EUR
What is the latest annual turnover for UCB NPV (PK)?
The latest annual turnover of UCB NPV (PK) is EUR 4.87B
What is the latest annual profit for UCB NPV (PK)?
The latest annual profit of UCB NPV (PK) is EUR 343M
What is the registered address of UCB NPV (PK)?
The registered address for UCB NPV (PK) is 60, ALLEE DE LA RECHERCHE, BRUSSELS, BRUSSELS-CAPITAL REGION, B-1070
What is the UCB NPV (PK) website address?
The website address for UCB NPV (PK) is www.ucb.com
Which industry sector does UCB NPV (PK) operate in?
UCB NPV (PK) operates in the CHEMICALS & ALLIED PRODUCTS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
DTEMFDitem Explorations (CE)
US$ 0.01
(999,900.00%)
1,000
RRMLFRoss River Minerals Inc (CE)
US$ 0.0089
(889,900.00%)
9.95k
FGHFFForte Group Holdings Inc (PK)
US$ 0.3833
(29,384.62%)
432
COUVCorporate Universe Inc (CE)
US$ 0.0002
(19,900.00%)
73.97k
SDCCQSmileDirectClub Inc (CE)
US$ 0.0002
(19,900.00%)
392.07k
CDJMCarnegie Development Inc (CE)
US$ 0.000001
(-100.00%)
2.58k
RAHGFRoan Holdings Group Company Ltd (CE)
US$ 0.000001
(-99.99%)
200
UBMRFUrbanimmersive Inc (CE)
US$ 0.000001
(-99.97%)
1.5k
UNDRUnderSea Recovery Corporation (CE)
US$ 0.000001
(-99.90%)
55k
EICCFE Automotive Inc (CE)
US$ 0.0001
(-99.88%)
5.67k
PHILPHI Group Inc (PK)
US$ 0.0005
(0.00%)
562.38M
GRLFGreen Leaf Innovations Inc (PK)
US$ 0.0001
(0.00%)
284.6M
RDARRaadr Inc (PK)
US$ 0.0016
(-5.88%)
170.08M
HMBLHUMBL Inc (PK)
US$ 0.00085
(6.25%)
153.18M
CGACCode Green Apparel Corp (PK)
US$ 0.0004
(-11.11%)
113.22M

Discussion

View Full Feed
Poo28 Poo28 2 minutes ago
DBMM is fully reporting and fully compliant. All regulators support DBMM’s potential and business which is executing the growth plan for the future. The SEC says Ignore these guys. No standing.

DBMM always prevails, the OIP Dismissal says in all. Tenacity and reality win the day. Go
DBMM OTCM
OMOLIVES OMOLIVES 2 minutes ago
I've used baking soda and lime juice in the past. Usually I am a little too buzzed to bother with such at night and say f' it :) I used to have an issue with nachos @ night...lol.
bas2020 bas2020 2 minutes ago
The company has over 5 years of detailed spoofing evidence. Go look it up...
NWBO
dstock07734 dstock07734 3 minutes ago
EX,

Why did they change the start date of the following trial with RevImmune as collaborator into the end of January? Is it coincidental?

Impact of Recombinant Human Interleukin-7 (CYT107) on Tumor Clearance and Immune Reconstitution in Multiple Myeloma Patients After
NWBO
Hardazoak Hardazoak 3 minutes ago
I heard the stockpile would last 20 years +
AABB
noradio noradio 3 minutes ago
I actually think the OTC is just starting another bull run that will dwarf the one in 20-21. What we saw recently with HMBL was just a taste of what's to come, this person explains it well...

https://x.com/ChartDiligence/status/1865056526416908756

https://x.com/ChartDil
HMBL
Poo28 Poo28 3 minutes ago
Hope real shareholders had Happy Holidays and a very Merry Christmas. We all share support for the future and the growth and launch of A1 products. The pivot to the future in tech model from beta to offering, is incredibly promising and will ensure DBMM’s best year in 2025. As a reminder, here is th
DBMM
Monksdream Monksdream 3 minutes ago
ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufa
ADMA
Shawonsarker84 Shawonsarker84 5 minutes ago
Setting up for massive success!
HMBL current status:
HMBL is number 9 on Breakout board
HMBL is number 3 on Most Read
HMBL is number 4 on Most Posted
HMBL is number 6 on Active Board

Don't forget HMBL broke the World Record in terms of the volume it
HMBL
3331 3331 5 minutes ago
LIFETIME LOSER, AS PATHETIC AS YOUR POST IS, IT'S ACTUALLY YOUR BEST SO FAR. ON THE BRIGHT SIDE, YOU CAN'T GET ANY WORSE!

IGNORANCE IS BLISS!
BIEL
northernwind2021 northernwind2021 6 minutes ago
Are you an idiot. I’m more excited about Phil than ever.

It all starts Tomorrow. Enjoy NEXT WEEK.

I’ll wait for your apology along with all other bashers who continuously discredit Henry. I expect all apologies sometime this week. I’ll be waiting.
PHIL
Hardazoak Hardazoak 6 minutes ago
100%
AABB
Green Leaf Smoker Green Leaf Smoker 6 minutes ago
**** 🚽MJNA🚽 Short high !!! cover low !!! .0001

PEE YEW !!! Stinky OTC pinky here

Rinse and repeat

ENOUGH SAID HUZZAH 🤪!!!
MJNA
Hardazoak Hardazoak 6 minutes ago
Cellar boxed is true.
AABB
bas2020 bas2020 7 minutes ago
Try to funnel this into your little pea brain... mgt can't buy shares ahead of material news; they must file a form 4. Look it up...
NWBO
Hardazoak Hardazoak 7 minutes ago
How do you really know what's happening at the aabb stockpile in etzatlan. Have you visited the site, or you just making lies up as you go.
AABB
jimr1717 jimr1717 7 minutes ago
Anyone else notice that the OS is about to double and a massive 12 million are getting ready to be Sold?
ATMH
Nee1 Nee1 8 minutes ago
This is all I have seen new, and it is 9 months old. The video they have shown for years seems slicker and faster, I suppose indicating progress. https://finance.yahoo.com/news/lithium-silicon-battery-market-set-123000881.html
StayHumble StayHumble 8 minutes ago
💹perSEC💹Rules $95 Possible,Correct Grandma?💹 @Idiot Mayor confirmed with the SEC

"i'm insider too bro. believe it"
https://cdn.vox-cdn.com/uploads/chorus_asset/file/8687957/tenor.gif
DBMM
gitreal gitreal 8 minutes ago
I think we have a Goldmine here...

You don't. But Jared sure does. He acquired a scam stock with a ready-made group of the dumbest, most gullible investors in the OTC. A multimillion dollar cabin on an island and a private security guard.... formerly paid for by MGX, now paid for b
MGX NBRI
georgebailey georgebailey 9 minutes ago
Deleted my response to a rhetorical Q
NWBO
bar1080 bar1080 9 minutes ago
Nasdaq listed tons of rubbish in the late1990s. After the Dot Com Crash in March 2000 something in excess of 600 very questionable stocks were delisted in short order. That occurred amid the Enron/World Com/ Health South accounting debacles and the demise of the formerly respected Arthur Anderson CP
ShawnP123 ShawnP123 11 minutes ago
It was actually the first two which referenced the same person. The last one was a totally different person and a different topic. However, in previous posts I suggested one listed to the Q3 conference from Nvidia and then listen to the Q4 from Broadcom. There is a big difference in the information
NVDA

Your Recent History

Delayed Upgrade Clock